Literature DB >> 8369594

Drug-induced cognitive impairment. Defining the problem and finding solutions.

J D Bowen1, E B Larson.   

Abstract

Drug-induced cognitive impairment is a common cause of delirium and is frequently a confounding factor in dementia. Predisposing conditions for delirium include age, brain disease and addiction to alcohol and/or drugs. The elderly are at particular risk because of multiple diseases, multiple drug use and alterations of drug metabolism associated with age. Sedatives such as benzodiazepines have a particularly high risk of cognitive impairment. Centrally acting sympathetic antihypertensive agents, sedating antipsychotic drugs, opioids, digitalis, anti-Parkinsonian drugs, antidepressants and corticosteroids are also associated with greater risk relative to other classes of medications. Cognitive impairment due to medication may be reduced by recognition of the problem. The risk of drug-induced impairment may be minimised by strategies which optimise overall health, avoidance of unnecessary medications, and selection of medications least likely to cause delirium.

Entities:  

Mesh:

Year:  1993        PMID: 8369594     DOI: 10.2165/00002512-199303040-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  36 in total

1.  Psychiatric morbidity in elderly surgical patients.

Authors:  H R Millar
Journal:  Br J Psychiatry       Date:  1981-01       Impact factor: 9.319

Review 2.  Implications of NSAID therapy in elderly patients.

Authors:  W W Buchanan
Journal:  J Rheumatol Suppl       Date:  1990-02

Review 3.  Neurological complications of antineoplastic therapy.

Authors:  W R Shapiro; D F Young
Journal:  Acta Neurol Scand Suppl       Date:  1984

4.  Dementia among medical inpatients. Evaluation of 2000 consecutive admissions.

Authors:  T Erkinjuntti; J Wikström; J Palo; L Autio
Journal:  Arch Intern Med       Date:  1986-10

5.  Psychotic complications of long-term levodopa treatment of Parkinson's disease.

Authors:  A Friedman; J Sienkiewicz
Journal:  Acta Neurol Scand       Date:  1991-08       Impact factor: 3.209

Review 6.  Pharmacological differences of serotonin reuptake inhibitors and possible clinical relevance.

Authors:  B E Leonard
Journal:  Drugs       Date:  1992       Impact factor: 9.546

7.  Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.

Authors:  R H Mattson; J A Cramer; J F Collins; D B Smith; A V Delgado-Escueta; T R Browne; P D Williamson; D M Treiman; J O McNamara; C B McCutchen
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

Review 8.  Anxiety in the elderly: treatment strategies.

Authors:  C Salzman
Journal:  J Clin Psychiatry       Date:  1990-10       Impact factor: 4.384

Review 9.  Clinical pharmacokinetic considerations in the elderly. An update.

Authors:  S Dawling; P Crome
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

Review 10.  Drug therapy in the elderly.

Authors:  J G Ouslander
Journal:  Ann Intern Med       Date:  1981-12       Impact factor: 25.391

View more
  12 in total

1.  Prevalence and correlates of psychotropic medication use among older adults in Israel: cross-sectional and longitudinal findings from two cohorts a decade apart.

Authors:  Tzvia Blumstein; Yael Benyamini; Angela Chetrit; Eliyahu H Mizrahi; Liat Lerner-Geva
Journal:  Aging Ment Health       Date:  2012       Impact factor: 3.658

2.  Alcohol use biomarkers predicting cognitive performance: a secondary analysis in veterans with alcohol dependence and posttraumatic stress disorder.

Authors:  Raj K Kalapatapu; Kevin L Delucchi; Brooke A Lasher; Sophia Vinogradov; Steven L Batki
Journal:  Mil Med       Date:  2013-09       Impact factor: 1.437

Review 3.  Drug-induced delirium. Incidence, management and prevention.

Authors:  G L Carter; A H Dawson; R Lopert
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

Review 4.  Restless patients in nursing homes. What is the role of drug therapy?

Authors:  P F Sinnett
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

5.  Is there a link between the use of benzodiazepines and related drugs and dementia? A systematic review of reviews.

Authors:  Patrícia Ferreira; Ana Rita Ferreira; Beatriz Barreto; Lia Fernandes
Journal:  Eur Geriatr Med       Date:  2021-08-17       Impact factor: 1.710

6.  Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population.

Authors:  Margaret A Pisani; Terrence E Murphy; Katy L B Araujo; Patricia Slattum; Peter H Van Ness; Sharon K Inouye
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

7.  Secondary psychoses: an update.

Authors:  Matcheri S Keshavan; Yoshio Kaneko
Journal:  World Psychiatry       Date:  2013-02       Impact factor: 49.548

8.  Cumulative anticholinergic exposure is associated with poor memory and executive function in older men.

Authors:  Ling Han; Joseph V Agostini; Heather G Allore
Journal:  J Am Geriatr Soc       Date:  2008-12       Impact factor: 5.562

Review 9.  Seizures in elderly patients with dementia: epidemiology and management.

Authors:  Mario Mendez; Gerald Lim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study.

Authors:  Pin-Liang Chen; Wei-Ju Lee; Wei-Zen Sun; Yen-Jen Oyang; Jong-Ling Fuh
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.